ad

Nifty Pharma Prediction for Tomorrow, 11 August 2026: Defensive Sector Holds as Energy Surge Bypasses API and Formulation Cost Structure

Nifty Pharma: 26,541.80 approx (-0.05% est. (crude headwind minimal; Sun Pharma and Cipla accumulation zones)). Mon 10 Aug. Crude +1.29% Rs 7,520. Nat Gas +3.33%. SBI -2.39%. ICICI +0.76%. VIX 12.19


10 Aug 20264:25 pm

Nifty Pharma Prediction for Tomorrow, 11 August 2026: Defensive Sector Holds as Energy Surge Bypasses API and Formulation Cost Structure

The Nifty Pharma prediction for tomorrow for Tuesday 11 August 2026 is built on Monday's confirmed market close. Nifty 50 settled at 24,583.80 (+0.05%), Sensex at 78,542.44 (+0.06%) and Bank Nifty at 57,686.95 (-0.10%). The session's defining story: Bajaj Finance recovered 2.24% to Rs 1,102.20 (resolving Friday's NBFC fear), SBI fell 2.39% on post-Q1 result profit booking and ICICI Bank bounced 0.76% confirming the Day 3 PSU-private rotation reversal. On the commodity side, MCX Crude surged 1.29% to Rs 7,520 and MCX Natural Gas jumped 3.33% to Rs 264.10, signalling Iran deal talks stalled. Nifty Pharma is the sectoral benchmark for this prediction for tomorrow. Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, present the complete Nifty Pharma prediction for tomorrow.

Click Here – Get Free Investment Predictions

Today's Confirmed Data for the Nifty Pharma prediction for tomorrow

Indicator Today's Close (Mon 10 Aug) Change
Nifty 50 24,583.80 +0.05% (H: 24,620.55 / L: 24,511.30)
Sensex 78,542.44 +0.06% (H: 78,672.08 / L: 78,305.94)
Bank Nifty 57,686.95 -0.10% (H: 58,012.60 / L: 57,527.75)
Nifty IT 31,631.45 +0.27%; Infosys +0.67%, TCS -1.10%
Nifty Auto 29,620.05 -0.09%; crude +1.29% is input cost headwind
Nifty Private Bank 27,534.30 +0.52%; ICICI Bank +0.76% Day 3 reversal
Nifty PSU Bank 8,639.80 -1.67%; SBI -2.39% post-Q1 booking
Nifty Metal 13,226.70 +0.28%; Hindustan Zinc positive
Bajaj Finance Rs 1,102.20 (+2.24%) Recovered from Friday crash; NBFC fear resolved
MCX Crude Oil (Aug) Rs 7,520/bbl (+1.29%) Iran deal stalled; biggest commodity move today
MCX Natural Gas (Aug) Rs 264.10/MMBTU (+3.33%) Biggest single-day surge this week; supply tightness
MCX Gold (10g) Rs 1,51,310/10g (+0.51%) Second positive session; range Rs 1,50,001-1,51,999
MCX Silver (Mini Aug) Rs 2,34,933/kg (+0.96%) Range Rs 2,32,299-2,36,300; precious metals bull intact
MCX Copper (Aug) Rs 1,375.70/kg (+0.75%) Range Rs 1,365.75-1,380.50; industrial demand positive
MCX Zinc (Aug) Rs 392.15/kg (+0.78%) Range Rs 388.20-393.80; supply deficit intact
India VIX 12.19 (+0.25%) Stable; range 10.82-12.92; no panic in market

Energy Surge: The Nifty Pharma prediction for tomorrow's Key Variable for Tomorrow

Monday's biggest market-moving development was not in equities but in energy commodities. MCX Crude Oil surged 1.29% to Rs 7,520 and MCX Natural Gas jumped 3.33% to Rs 264.10, both confirming that Iran-US deal negotiations stalled over the weekend. Ankit Jaiswal notes that this energy surge has direct sector implications for tomorrow: it is a headwind for Auto, FMCG and Cement (higher input costs) and a tailwind for ONGC and the broader energy sector. for tomorrow, monitoring Brent crude direction Tuesday morning is as important as watching domestic banking recovery.

Kunal Singla observes that Natural Gas at Rs 264.10 is the highest level in over two months, reversing all of the Iran-deal-hope-driven decline from Rs 280+ levels in June. for tomorrow, if crude and gas continue higher Tuesday, defensive sectors (IT, healthcare, FMCG) would outperform cyclicals (auto, cement) in the prediction for tomorrow session.

Key Factors for the Nifty Pharma prediction for tomorrow

  • Nifty Pharma holds its defensive position heading into the Nifty Pharma prediction for tomorrow. Pharma companies' primary input costs are APIs (Active Pharmaceutical Ingredients), excipients and solvents. Crude oil's 1.29% Monday surge creates minimal direct pressure, as API synthesis uses controlled chemical processes with costs primarily tied to natural gas (modestly higher after Monday's +3.33% surge) and electricity, not crude.
  • Sun Pharma at Rs 1,945 and Cipla at Rs 1,463.80 remain in their post-Q1 FY27 results profit-booking correction zones. for tomorrow, these are accumulation-not-selling levels: both companies reported strong Q1 results and the mild price corrections since are standard post-results behaviour.
  • The crude-energy surge on Monday actually benefits the Nifty Pharma prediction for tomorrow through defensive sector rotation. When crude rises 1.29% and auto and FMCG face margin headwinds, institutional money rotates to crude-insensitive sectors. Pharma is historically the second most common crude-surge defensive rotation sector after IT.
  • Apollo Hospitals at Rs 8,945 provides the Nifty Pharma prediction for tomorrow domestic demand anchor: India's private hospital capacity expanding 12% year-on-year, health insurance penetration rising 18% and NHCEF scheme expansion all create structural Apollo demand independent of crude's Monday move.

Technical Levels for the Nifty Pharma prediction for tomorrow

Level Zone
Key Support 26,380-26,430
Secondary Support 26,080-26,150
Immediate Resistance 26,680-26,780
Key Resistance 26,940-27,060

Stocks to Watch for the Nifty Pharma prediction for tomorrow

Sun Pharma: CMP Rs 1,945 approx. Ankit Jaiswal flags entry Rs 1,928-1,942, target Rs 1,992, SL Rs 1,896. Sun Pharma is the Nifty Pharma prediction for tomorrow primary stock. Defensive rotation from crude headwinds supports entry at Rs 1,928-1,942.

Cipla: CMP Rs 1,463.80 approx. Kunal Singla flags entry Rs 1,454-1,462, target Rs 1,498, SL Rs 1,428. Cipla's diversified India-US balanced portfolio provides fundamental support for tomorrow.

Apollo Hospitals: CMP Rs 8,945 approx. Ankit Jaiswal flags entry Rs 8,880-8,940, target Rs 9,120, SL Rs 8,720. Apollo Hospitals provides domestic healthcare demand anchoring for tomorrow independent of crude.

Use Univest Screener to Prepare for tomorrow

Strategy for the Nifty Pharma prediction for tomorrow

  1. Rs 26,380-26,430 is the Nifty Pharma prediction for tomorrow primary support. Ankit Jaiswal recommends adding pharma positions here given the defensive rotation thesis.
  2. Rs 26,680-26,780 is the first Nifty Pharma prediction for tomorrow resistance.
  3. Track Sun Pharma at Rs 1,928-1,942 as the Nifty Pharma prediction for tomorrow accumulation zone for tomorrow.
  4. If crude sustains above Rs 7,520 Tuesday morning, the Nifty Pharma prediction for tomorrow benefits from continued defensive rotation out of auto and FMCG.

Risks to the Nifty Pharma prediction for tomorrow

  • US FDA warning letters on Indian pharma facilities creating sector headwinds in the Nifty Pharma prediction for tomorrow.
  • Natural Gas +3.33% raising pharmaceutical energy-intensive solvent and fermentation costs in the Nifty Pharma prediction for tomorrow.
  • Risk-on rally from Bajaj Finance recovery creating full-market strength that reduces defensive rotation into pharma in the Nifty Pharma prediction for tomorrow.

Conclusion

The Nifty Pharma prediction for tomorrow for Tuesday 11 August 2026 is shaped by three resolved positives from Monday: Bajaj Finance +2.24% (NBFC fear gone), ICICI Bank +0.76% (private bank Day 3 reversal confirmed) and SBI post-Q1 booking potentially exhausted at Rs 1,071. The primary new risk is energy: crude +1.29% to Rs 7,520 and Natural Gas +3.33% to Rs 264.10 signal Iran deal stalled, creating input cost headwinds for auto and FMCG in the Nifty Pharma prediction for tomorrow. Ankit Jaiswal of Univest identifies 26,380-26,430 as the primary support and 26,680-26,780 as the resistance for tomorrow on Tuesday.

Kunal Singla of Univest recommends the three-check approach for tomorrow: Brent crude direction pre-market (key for sector rotation in the Nifty Pharma prediction for tomorrow), Bajaj Finance opening above Rs 1,100 (NBFC recovery sustaining) and ICICI Bank above Rs 1,435 (Day 4 private bank recovery continuing). VIX at 12.19 confirms stable volatility for tomorrow on Tuesday.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Verify all data with NSE (nseindia.com) and BSE (bseindia.com) before investing. Investments are subject to market risk. This content is for educational purposes only and does not constitute investment advice by Univest (SEBI RA INH000013776).

Download the Univest iOS App or Univest Android App to track live levels and receive Tuesday morning alerts for tomorrow.

FAQs on Nifty Pharma Prediction For Tomorrow, 11 August 2026

What is the Nifty Pharma prediction for tomorrow, 11 August 2026?

Ans. The Nifty Pharma prediction for tomorrow is neutral to positive. Pharma is minimally affected by crude's 1.29% surge and benefits from defensive rotation. Sun Pharma and Cipla are in accumulation zones. Support is 26,380-26,430 and resistance is 26,680-26,780 in the Nifty Pharma prediction for tomorrow.

Which analysts prepared the Nifty Pharma prediction for tomorrow?

Ans. Ankit Jaiswal, Senior Research Analyst, and Kunal Singla, Associate Director at Univest, prepared the Nifty Pharma prediction for tomorrow.

How does crude at Rs 7,520 affect the Nifty Pharma prediction for tomorrow?

Ans. Crude has minimal direct impact on pharma. APIs and excipients are not crude-sensitive. Natural Gas +3.33% mildly raises fermentation energy costs (2-4 basis points), but defensive rotation from crude-pressured cyclicals is more impactful for tomorrow.

What is Nifty Pharma support and resistance for the prediction for tomorrow?

Ans. Support is 26,380-26,430 and 26,080-26,150. Resistance is 26,680-26,780 and 26,940-27,060 in the Nifty Pharma prediction for tomorrow.

What stocks are watched in the Nifty Pharma prediction for tomorrow?

Ans. Sun Pharma (accumulation at Rs 1,928-1,942), Cipla (India-US balanced portfolio support) and Apollo Hospitals (domestic healthcare anchor) are the three stocks in the Nifty Pharma prediction for tomorrow.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down